MAC Clinical Research is pleased to announce the successful dosing of the first participant in a Phase 2 clinical study investigating a psychedelic investigational compound
MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase 1 Multiple Ascending Dose (MAD)
MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient receptor potential cation channel vanilloid
At MAC Clinical Research, we believe in transparency, collaboration, and driving conversations that matter in clinical research. Over the past months, we’ve worked closely with
Clinical research is constantly evolving, but one thing remains unchanged: the need for open conversations. From patient diversity and participant recruitment to operational processes and
April is Stress Awareness Month and a perfect opportunity to reflect on the stress in our lives and how we can effectively manage it. Stress
Taking a new treatment from lab to patient is a long, highly regulated process that demands years of research, significant investment and close collaboration between
MAC Clinical Research is delighted to announce that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved amendments to the Clinical Trial Application
Effective project management is vital to the success of a clinical trial, helping to ensure that studies are conducted smoothly, efficiently, and in line with
At the end of 2024, MAC Laboratory Services reached an exciting milestone: full accreditation under the Good Laboratory Practice (GLP) Monitoring Scheme. The impact of
